GlaxoSmithKline

-$0.49 (-1.07%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GSK and other ETFs, options, and stocks.

About GSK

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare.

CEO
Emma N. Walmsley
Employees
94,066
Headquarters
Middlesex, Greater London
Founded
1999

GSK Key Statistics

Market cap
113.31B
Price-Earnings ratio
19.06
Dividend yield
4.79
Average volume
6.13M
High today
$45.31
Low today
$44.82
Open price
$45.23
Volume
3.88M
52 Week high
$46.86
52 Week low
$33.53

GSK News

ReutersJan 25

Unilever's soap opera: M&A, job cuts and grumpy investors

(Reuters) - Unilever unveiled plans on Tuesday to cut about 1,500 management jobs in an overhaul aimed at easing shareholders' concerns after a failed acquisiti
ReutersJan 25

Saudi Arabia agrees deal with GSK to develop healthcare sector - tweet

A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls DUBAI, Jan 25 (Reuters) - Saudi
ReutersJan 24

U.S. FDA to restrict use of Regeneron, Lilly COVID antibody drugs - WaPo

Jan 24 (Reuters) - The U.S. Food and Drug Administration (FDA) is likely to restrict the use of COVID-19 antibody treatments from Regeneron and Eli Lilly as the

GSK Earnings

$0.00
$0.34
$0.67
$1.01
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Available Feb 9

More GSK News

New York TimesJan 23

Nelson Peltz Takes Aim at Unilever

LONDON — Only days ago, Unilever suffered a big defeat when it was forced to drop its $68 billion bid for GlaxoSmithKline’s consumer health business. Now it mu
The Wall Street JournalJan 23

Activist Investor Nelson Peltz Buys Stake in Unilever

LONDON—Trian Fund Management LP, the activist hedge fund run by Nelson Peltz, has acquired a stake in Unilever UL -0.18% PLC, according to people familiar with
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure